About LieffCabraser

"One of the nation's premier plaintiffs firms," Lieff Cabraser has 120 lawyers in San Francisco, New York, Nashville, and Munich. We have a widely diversified practice successfully representing plaintiffs in the fields of personal injury and mass torts, securities and financial fraud, employment discrimination and unlawful employment practices, product defect, consumer protection, antitrust, environmental and toxic exposures, False Claims Act, digital privacy and data security, and civil and human rights. Our clients include individuals, classes and groups of people, businesses, and public and private entities.

Judge in USC Tyndall Sex Abuse Gender Violence Case Signals Approval of Landmark $215M Settlement for Ex-Gynecologist’s Patients

On Monday January 6, 2020 a federal judge in Los Angeles signaled that he would give final approval to USC’s landmark, $215-million federal class-action settlement with former patients of Dr. George Tyndall, who has been accused of sexual abuse and misconduct relating to tens of thousands of female patients while he was the head gynecologist

2020-01-06T17:12:33+00:00January 6th, 2020|Personal Injury, Sexual Abuse|

Class Counsel Announce U.S. District Court Grants Final Approval to $135m Settlement in Navistar Diesel Engine EGR Emissions Defect Litigation

Owners and lessees of affected vehicles must file their claims by May 11, 2020 to recover up to $2,500 cash, up to $10,000 rebate on a new Navistar truck, or up to $15,000 for documented costs relating to the alleged defect January 3, 2020, New York—(BUSINESSWIRE)—On January 3rd, 2020, Judge Joan B. Gottschall of the

2020-01-03T17:29:49+00:00January 3rd, 2020|Defective Products|

Nashville News Anchor Demetria Kalodimos and TV Station WSMV Resolve Dispute

As reported by The Nashville Business Journal, longtime news anchor Demetria Kalodimos announced Wednesday that she has settled her lawsuit with her former employer, WSMV Channel 4, an NBC-affiliated television station in Nashville, Tennessee. The lawsuit against WSMV and the station’s owner, Meredith Corp., accused the media companies of gender and age discrimination as well

2020-01-03T13:52:31+00:00January 3rd, 2020|Employment Law|

Lieff Cabraser Names New Partners for 2020

We are proud to announce that Andrew Kaufman, Kelly McNabb, John Nicolaou, and Tiseme Zegeye have been promoted to partner. Andrew, who works in our Nashville office, has a practice that focuses on financial fraud, consumer protection, and product defect cases. John and Kelly are located in New York City, where John works on securities

2022-09-21T17:44:15+00:00January 1st, 2020|Firm News|

American Antitrust Institute Successfully Opposes Drug Makers’ Attempts to Enjoin New California Law Outlawing Pay-for-Delay Drug Settlements

Lieff Cabraser serves as counsel for amicus AAI, who successfully secured denial of drug makers’ requested injunction against the new pro-competition law AB 824 Lieff Cabraser serves as counsel for amicus American Antitrust Institute, on whose behalf the firm filed a brief in opposition to drug makers’ attempts to enjoin a new California law (AB

2019-12-31T14:47:16+00:00December 31st, 2019|Amicus, Antitrust|

Health Organizations Warn More Children Are Swallowing Dangerous Toy Magnets

As reported by The Washington Post, the number of children ingesting rare-earth magnets — often made into desktop toys — has skyrocketed in the last three years. When ingested, these tiny magnets are capable of shredding a child’s intestines as they are often 10 times stronger than ordinary magnets. As The Post notes, “if multiple

2019-12-26T14:59:23+00:00December 26th, 2019|Infant & Child Injuries|

Lieff Cabraser Announces Settlement of Lovenox/Enoxaparin Drug Antitrust Class Action with Momenta and Sandoz

$120 million aggregate settlement will benefit hospitals, insurers and companies that pay for their employees’ healthcare costs, and uninsured people affected by the pharma companies’ alleged anticompetitive conduct Lieff Cabraser is proud to announce that Momenta Pharmaceuticals, Inc. and Sandoz Inc. have agreed to settlements totaling $120 million in the antitrust class action about enoxaparin,

2019-12-22T14:23:27+00:00December 22nd, 2019|Antitrust|